Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
Apurva Hariharan, Abdul Rahman Hakeem, Subathra Radhakrishnan, et al.
Inflammopharmacology (2020) Vol. 29, Iss. 1, pp. 91-100
Open Access | Times Cited: 266

Showing 1-25 of 266 citing articles:

The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang, Xueru Xie, Zikun Tu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 498
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 206
Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 103
COVID-19 and the role of cytokines in this disease
Amin Hasanvand
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 789-798
Open Access | Times Cited: 92
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 78
Classic Signaling Pathways in Alveolar Injury and Repair Involved in Sepsis-Induced ALI/ARDS: New Research Progress and Prospect
Wenli Li, Duo Li, Yuansen Chen, et al.
Disease Markers (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 70
The role of oxidative stress in the pathogenesis of infections with coronaviruses
Chandrima Gain, Sihyeong Song, Tyler Angtuaco, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 56
The role and therapeutic potential of nuclear factor κB (NF-κB) in ischemic stroke
Guangyu Xu, Fang Dong, Lei Su, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116140-116140
Open Access | Times Cited: 20
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112420-112420
Open Access | Times Cited: 99
The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?
Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, et al.
Cytokine (2021) Vol. 144, pp. 155593-155593
Open Access | Times Cited: 86
The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19
Ali Attiq, Lui Jin Yao, Sheryar Afzal, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108255-108255
Open Access | Times Cited: 78
Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis
Radha Gopalaswamy, Selvakumar Subbian
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3773-3773
Open Access | Times Cited: 73
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
Ali A. Rabaan, Shamsah H. Al-Ahmed, Mohammed Garout, et al.
Pathogens (2021) Vol. 10, Iss. 5, pp. 565-565
Open Access | Times Cited: 73
Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19)
Amir Hossein Norooznezhad, Kamran Mansouri
Microvascular Research (2021) Vol. 137, pp. 104188-104188
Open Access | Times Cited: 72
COVID-19: Inflammatory Profile
Yuhang Wang, Stanley Perlman
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 65-80
Open Access | Times Cited: 71
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaaser Q. Almulaiky, et al.
European Journal of Pharmacology (2021) Vol. 904, pp. 174196-174196
Open Access | Times Cited: 60
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul, Luis Alberto Bravo-Vázquez, Paula Reyes‐Pérez, et al.
Virus Research (2021) Vol. 308, pp. 198631-198631
Open Access | Times Cited: 56
Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes
Elisabeth Taucher, Iurii Mykoliuk, Joerg Lindenmann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109428-109428
Open Access | Times Cited: 47
Role and mechanisms of the NF-ĸB signaling pathway in various developmental processes
Peiqi Liu, Yue Li, Weilin Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113513-113513
Open Access | Times Cited: 46
NF-κB Signaling and Inflammation—Drug Repurposing to Treat Inflammatory Disorders?
Annabell Roberti, Laura Elizabeth Chaffey, David R. Greaves
Biology (2022) Vol. 11, Iss. 3, pp. 372-372
Open Access | Times Cited: 44
Role of CCL2/CCR2 axis in the pathogenesis of COVID-19 and possible Treatments: All options on the Table
Mitra Ranjbar, Ali Rahimi, Zeinab Baghernejadan, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109325-109325
Open Access | Times Cited: 44
An updated overview of recent advances, challenges, and clinical considerations of IL-6 signaling blockade in severe coronavirus disease 2019 (COVID-19)
Reza Elahi, Parsa Karami, Amir Hossein Heidary, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108536-108536
Open Access | Times Cited: 43
Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview
Anamika Gupta, Hezlin Marzook, Firdos Ahmad
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 2, pp. 313-331
Open Access | Times Cited: 43
Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson’s and Alzheimer’s Disease
Sachchida Nand, Neeraj Tiwari, Payal Singh, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top